MO-ASM-GLOBAL
23.5.2024 18:01:32 CEST | Business Wire | Press release
Bass Pro Shops Big Cedar Lodge announced today that on July 21 the Ozarks will rock as the ancient hills, valleys and lakes never have when the world’s greatest rock-and-roll band, The Rolling Stones, light up Thunder Ridge Nature Arena for the last performance on their final North American tour.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523211894/en/
Rendering of Thunder Ridge Nature Arena (Graphic: Business Wire)
The concert promises to be one of the most memorable and highly anticipated concert events ever. It is a pairing of the World’s Greatest Rock-and-Roll Band and the most breathtaking and awe-inspiring outdoor amphitheater in all of North America.
The Thunder Ridge concert stop is part of the “Hackney Diamonds Tour ’24” for The Rolling Stones, which includes 20 performances in 16 cities. Tickets will go on sale Friday, May 31, and will be available at ThunderRidgeNatureArena.com.
“We’re honored to host The Rolling Stones at Thunder Ridge Nature Arena and to showcase the amazing beauty of the Ozarks to music fans of all generations,” said Johnny Morris, visionary conservationist and founder of Bass Pro Shops. “The Stones are the most iconic rock-and-roll band ever, and we know they will put on a remarkable show that no one will ever forget! Their appearance will become a part of the history of this beautiful mountain in the Ozarks.”
Thunder Ridge is a world-class destination admired by legends of rock.
Representatives from The Rolling Stones scouted Thunder Ridge by attending the sold-out Garth Brooks concert in September 2022. After attending the show, the advance team reported back that Thunder Ridge was one of the most extraordinary and beautiful event venues they had ever seen.
A legendary night of entertainment began on a fishing trip with two of the leading conservationists of our time.
A partnership between The Rolling Stones, the Ozarks and Johnny Morris is something few would have expected; but, in fact, this is a relationship decades in the making. More than 20 years ago, the Stones renowned keyboard and piano player, Chuck Leavell, joined Johnny Morris to celebrate the opening of a Bass Pro Shops near Chuck’s home in Macon, Georgia. Out of this shared experience, Johnny and Chuck developed a special friendship founded on conservation, a love of the outdoors and a few remarkable shared fishing adventures. And now their adventure continues with a concert unlike anything that has ever been seen in the Ozarks.
A noted conservationist, Chuck Leavell is one of only three recipients of an Honorary Forest Ranger award from the U.S. Forest Service and is also a past recipient of the National Outstanding Tree Farmer award. Johnny Morris, is also a legend in conservation and is a recipient of the prestigious Audubon Medal, considered by many to be the highest award in conservation. In the 114-year history of Audubon there have been only 57 recipients for this prestigious award.
Awe-inspiring, nature-based entertainment venue.
The Rolling Stones concert at Thunder Ridge Nature Arena underscores Johnny’s commitment to create one of the finest outdoor entertainment venues in North America and shares the beauty of his beloved Ozarks with others for generations to come. It’s more than just a place for spectacular concerts, rodeos and conventions. The property has been placed in a not-for-profit foundation, and all proceeds from events at the arena will go to further enhance the facilities and support conservation.
Located on about 1,200 acres near Ridgedale, Thunder Ridge is adjacent to the Bass Pro Shops Big Cedar Lodge on land originally purchased by Johnny Morris about 30 years ago. For the past decade, it has accommodated large gatherings, including concerts by Garth Brooks, Hank Williams Jr., Chris Janson, Dierks Bentley, Tracy Lawrence and other major acts.
It also has hosted air shows, hot air balloon shows, the U.S. Open Bowfishing Championship, the U.S. Open National Bass Tournament, the National 4-H Youth Council, rodeos, conventions, symposiums and special events and is set to host nature-based activities for all ages and interests for years to come.
Thunder Ridge is the latest jewel in Big Cedar Lodge’s proud tradition of hosting world-class hospitality and entertainment experiences that span a variety of recreational markets.
The vision for the future is to continue to host a wide variety of world-class outdoor events. The Rolling Stones performance is only the latest in a summer full of marquee concerts already announced for Thunder Ridge. This lineup includes:
- May 25 – Morgan Wallen
- June 13 – Chris Stapleton
- June 15 – Fuerza Regida
- July 21 – The Rolling Stones
- July 27 – Luke Bryan
- Aug. 31 – Slightly Stoopid & Dirty Heads w / HIRIE
- Sept. 8 – Imagine Dragons
- Sept. 21 – Pitbull
More than six decades of rock-and-roll royalty.
Over the last 60 years, The Rolling Stones have defined the rock-and-roll movement, led by vocalist Mick Jagger and guitarist Keith Richards. The group has estimated album sales of 250 million, making them one of the best-selling musical artists of all time.
The Stones have released 30 studio albums, 23 live albums and 12 official compilation albums; and CNN has called them “far and away the most successful act in rock today.” The Grammy Award-winning band was inducted into the Rock & Roll Hall of Fame in 1989 and the U.K. Music Hall of Fame in 2004 and have been ranked by music-industry watchdogs Billboard magazine and Rolling Stone magazine as one of the greatest bands of all time.
This tour is in support of their widely heralded Hackney Diamonds album release from 2022, which received rave reviews from fans and music critics everywhere.
About Thunder Ridge Nature Arena
Thunder Ridge Nature Arena is a breathtaking outdoor amphitheater nestled in the heart of the Ozarks in Ridgedale, Missouri, just a few miles south of Branson. Situated on over 1,200 acres of land dedicated to conservation, the venue offers stunning views of Table Rock Lake and the Boston Mountains of Arkansas. Thunder Ridge Nature Arena is part of the Johnny Morris Conservation Foundation, dedicated to preserving and celebrating the natural beauty of the Ozarks. All venue proceeds go directly to conservation efforts to protect the land, wildlife and natural habitats of the Ozark region.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240523211894/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom